Patents Assigned to Centre National De Recherche Scientifique (CNRS)
  • Patent number: 9802061
    Abstract: The disclosure is related to an apparatus and method for charged hadron therapy verification. The apparatus comprises a collimator comprising a plurality of collimator slabs of a given thickness, spaced apart so as to form an array of mutually slit-shaped openings, configured to be placed at a right angle to the beam line, so as to allow the passage of prompt gammas from the target, the collimator being defined at least by three geometrical parameters being the width and depth of the slit-shaped openings and a fill factor. The disclosure is also related to a method for charged hadron therapy verification with a multi-slit camera.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: October 31, 2017
    Assignees: Ion Beam Applications S.A., Université Claude Bernard Lyon 1, Institut National des Science Appliquées de Lyon, Centre National de Recherche Scientifique (CNRS)
    Inventors: Nicolas Freud, Frauke Roellinghoff, Etienne Testa, Marco Pinto, Julien Smeets
  • Publication number: 20160319306
    Abstract: The present invention relates, inter alia, to recombinant Gram-positive Clostridia host cells for producing solvents, fuels and/or chemical intermediates, and preferably ethanol, from plant cell walls comprising: (a) at least one nucleic acid encoding a plant cell wall degrading enzyme, wherein the host cells produce and secrete the plant cell wall degrading enzyme, (b) at least one nucleic acid encoding an enzyme that converts pyruvate to acetaldehyde and at least one nucleic acid encoding an enzyme that converts acetaldehyde to ethanol wherein the host cell is capable of expressing said nucleic acid, and, (c) a mutation in at least one nucleic acid encoding for an enzyme in a metabolic pathway which produces a metabolite other than acetaldehyde from pyruvate or ethanol from acetaldehyde, such that the mutation results in a reduced production of the metabolite.
    Type: Application
    Filed: June 24, 2016
    Publication date: November 3, 2016
    Applicants: Total Marketing Services, Le Centre National De Recherche Scientifique (CNRS), Université D'Aix Marseille, L'Institut National des Sciences Appliquées (INSA)
    Inventors: Laurence GIRBAL, Florence Saint-Prix, Mathieu Cesari, Henri-Pierre Fierobe, Roberto Mazzoli, Florence Mingardon, Angélique Chanal-Vial
  • Patent number: 9441213
    Abstract: Described herein are molecules, constructs and methods for the production and secretion of polypeptides of interest by host cells, preferably bacterial host cells, and more particularly gram positive bacteria. In particular, the present invention is related to a polynucleic acid encoding a fusion protein and to uses thereof for the secretion of heterologous or homologous polypeptides of interest by a bacterial host cell, preferably Clostridium bacteria. The present invention further relates to methods and constructs for the production and secretion of heterologous or homologous polypeptides of interest proteins by host cells using such polynucleic acids and fusion proteins.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: September 13, 2016
    Assignees: Total Marketing Services, Le Centre National De Recherche Scientifique (CNRS), Université d'Aix-Marseille, L'Institut National des Sciences Appliquées (INSA)
    Inventors: Henri-Pierre Fierobe, Florence Mingardon, Angélique Chanal-Vial
  • Patent number: 9382306
    Abstract: The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal 1-cyclo(Cys2-Tyr3-AA4-Lys5-Val6-Cys7)-Thr8-NH2. Since these products have a good affinity for certain somatostatin receptor subtypes, they are particularly advantageous for treating pathological states or diseases in which one (or more) somatostatin receptor(s) is (are) involved. These compounds furthermore have physiochemical properties that make it possible to envisage them in diverse solutions for the formulation of medicaments, for example as a pharmaceutically acceptable carrier. The invention also relates to pharmaceutical compositions containing said products and to the use thereof for the preparation of a medicament.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: July 5, 2016
    Assignees: IPSEN PHARMA S.A.S., COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA), LE CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Marie-Thérèse Paternostre, Jean-Christophe Cintrat, Céline Valery, Stéphane Roux, Bernard Rousseau, Maarten Ijsselstijn, Roland Cherif-Cheikh, Franck Artzner
  • Publication number: 20140373550
    Abstract: The invention relates to a rear casing for a turbine engine comprising a primary body generating a primary flow (10) to be ejected through a primary nozzle (6), said rear casing (7) being shaped so as to be positioned downstream from the primary body and to define, on the inside of the turbine engine, the path followed by the primary flow downstream from the primary nozzle (6). The tail cone is characterised in that it comprises a connection to a system for supplying a pressurised gas and at least one perforation (8) for injecting the pressurised gas through the perforation and into the primary flow. The casing preferably comprises at least one means for rotating same about the axis of rotation of the mobile elements of the primary body.
    Type: Application
    Filed: July 8, 2014
    Publication date: December 25, 2014
    Applicants: SNECMA, Centre National De Recherche Scientifique (CNRS), UNIVERSITE DE POITIERS, ENSMA
    Inventors: Alexandre Alfred Gaston VUILLEMIN, Maxime KOENIG, Peter JORDAN, Pierre COMTE, Yves GERVAIS
  • Patent number: 8871479
    Abstract: The invention relates to applications of the cellulase Cel5H of Saccharophagus degradans and its homologues, functional fragments and/or variants and engineered forms thereof, in the context of recombinant, more particularly solventogenic microorganisms, more particularly C. acetobutylicum. The invention also characterizes a novel domain of the Cel5H cellulase with a putative cellulose-binding module function, and its uses in chimeric proteins for depolymerization of cellulose containing substrates.
    Type: Grant
    Filed: November 26, 2009
    Date of Patent: October 28, 2014
    Assignees: Total Marketing Services, Le Centre National de Recherche Scientifiques (CNRS), L'Institut National des Sciences Appliquees (INSA), Universite d'Aix-Marseille
    Inventors: Henri-Pierre Fierobe, Angélique Chanal-Vial, Anne-Laure Molinier, Chantal Tardif, Luc Dedieu
  • Patent number: 8462031
    Abstract: Continuous time analogue/digital converter, comprising a sigma delta modulator (MSD1) configured to receive an analogue input signal (x(t)) and comprising high-pass filtering means (MF) the chopping frequency of which is equal to half of the sampling frequency (Fs) of the quantization means (QTZ) of the modulator (MSD1).
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: June 11, 2013
    Assignees: STMicroelectronics SA, Centre National de Recherche Scientifique (CNRS)
    Inventors: Didier Belot, Jean-Baptiste Begueret, Yann Deval, Dominique Dallet, André Mariano
  • Publication number: 20130115669
    Abstract: The present invention relates, inter alia, to recombinant Gram-positive Clostridia host cells for producing solvents, fuels and/or chemical intermediates, and preferably ethanol, from plant cell walls comprising: (a) at least one nucleic acid encoding a plant cell wall degrading enzyme, wherein the host cells produce and secrete the plant cell wall degrading enzyme, (b) at least one nucleic acid encoding an enzyme that converts pyruvate to acetaldehyde and at least one nucleic acid encoding an enzyme that converts acetaldehyde to ethanol wherein the host cell is capable of expressing said nucleic acid, and, (c) a mutation in at least one nucleic acid encoding for an enzyme in a metabolic pathway which produces a metabolite other than acetaldehyde from pyruvate or ethanol from acetaldehyde, such that the mutation results in a reduced production of the metabolite.
    Type: Application
    Filed: January 9, 2013
    Publication date: May 9, 2013
    Applicants: Total S.A., Le Centre National De Recherche Scientifique (CNRS, L'Institut National des Sciences Appliquées (INSA), L'Université de Provence, L'Université de la Mediterranée
    Inventors: Laurence GIRBAL, Florence Saint-Prix, Mathieu Cesari, Henri-Pierre Fierobe, Roberto Mazzoli, Florence Mingardon, Angélique Chanal-Vial
  • Publication number: 20130032650
    Abstract: A method for controlled reduction of the weight average molar mass of a polysaccharide down to a lower and determined weight average molar mass, which method includes a step for mechanical milling of the polysaccharide by a ball mill, until the polysaccharide having the desired weight average molar mass is obtained.
    Type: Application
    Filed: November 29, 2010
    Publication date: February 7, 2013
    Applicants: CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE - CNRS, INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER-IFREMER, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6 )
    Inventors: Claire Boisset, Tinaig Le Costaouec, Joelle Cozien, Corinne Sinquin, Jacqueline Ratiskol, William Helbert, Gaelle Correc, Veronique Larreta Garde
  • Publication number: 20120122176
    Abstract: The invention relates to applications of the cellulase Cel5H of Saccharophagus degradans and its homologues, functional fragments and/or variants and engineered forms thereof, in the context of recombinant, more particularly solventogenic microorganisms, more particularly C. acetobutylicum. The invention also characterizes a novel domain of the Cel5H cellulase with a putative cellulose-binding module function, and its uses in chimeric proteins for depolymerization of cellulose containing substrates.
    Type: Application
    Filed: November 26, 2009
    Publication date: May 17, 2012
    Applicants: Total S.A., Le Centre National De Recherche Scientifique (CNRS), L'Institut National des Sciences Appliquees (INSA), L'Universite de Provence, L'Universite de la Mediterranee
    Inventors: Henri-Pierre Fierobe, Angélique chanal-Vial, Anne-Laure Molinier, Chantal Tardif, Luc Dedieu
  • Publication number: 20110294184
    Abstract: The invention relates to applications of a cellulase of Pseudomonas sp. ND137, functional fragments and/or variants and engineered forms thereof, in the context of industrial bioprocessing, more particularly solvent production.
    Type: Application
    Filed: November 26, 2009
    Publication date: December 1, 2011
    Applicants: Total S.A., Le Centre National De Recherche Scientifique (CNRS), L'Institut National des Sciences Appliquees (INSA), L'Universite de Provence, L'Universite de la Mediterranee
    Inventors: Henri-Pierre Fierobe, Angélique Chanal-Vial
  • Publication number: 20110236943
    Abstract: The present invention relates, inter alia, to recombinant Gram-positive Clostridia host cells for producing solvents, fuels and/or chemical intermediates, and preferably ethanol, from plant cell walls comprising: (a) at least one nucleic acid encoding a plant cell wall degrading enzyme, wherein the host cells produce and secrete the plant cell wall degrading enzyme, (b) at least one nucleic acid encoding an enzyme that converts pyruvate to acetaldehyde and at least one nucleic acid encoding an enzyme that converts acetaldehyde to ethanol wherein the host cell is capable of expressing said nucleic acid, and, (c) a mutation in at least one nucleic acid encoding for an enzyme in a metabolic pathway which produces a metabolite other than acetaldehyde from pyruvate or ethanol from acetaldehyde, such that the mutation results in a reduced production of the metabolite.
    Type: Application
    Filed: December 2, 2009
    Publication date: September 29, 2011
    Applicants: Total S.A, Le Centre National de Recherche Scientifique (CNRS), L'Universite de la Mediterranee, L'Universite de Provence, L'Institut National des Sciences Appliquees (INSA)
    Inventors: Laurence Girbal, Florence Saint-Prix, Mathieu Cesari, Henri-Pierre Fierobe, Roberto Mazzoli, Florence Mingardon, Angélique Chanal-Vial
  • Publication number: 20110211197
    Abstract: The disclosure relates to a detection device for imaging an object, that comprises: a laser cavity for transmitting an original light signal at an original wavelength towards the object in order to generate an evanescent wave at the surface of the object; a conversion means adapted for converting the evanescent wave into a progressive signal; a re-injection means adapted for injecting the progressive signal into the laser cavity in order to generate interference inside the laser cavity between the progressive signal and the original light signal; a detection means adapted for detecting the interference in order to determine the characteristics of the object; characterised in that the device includes a wavelength modification means adapted so that the wavelength of the progressive signal injected into the laser cavity is different from the original wavelength.
    Type: Application
    Filed: September 3, 2008
    Publication date: September 1, 2011
    Applicant: CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Sylvain Girard, Hervé Gilles, Mathieu Laroche
  • Publication number: 20110178013
    Abstract: The present invention relates to novel octapeptide compounds of general formula (I): H-2-Nal1-cyclo(Cys2-Tyr3-AA4-Lys5-Val6-Cys7)-Thr8-NH2. Since these products have a good affinity for certain somatostatin receptor subtypes, they are particularly advantageous for treating pathological states or diseases in which one (or more) somatostatin receptor(s) is (are) involved. These compounds furthermore have physiochemical properties that make it possible to envisage them in diverse solutions for the formulation of medicaments, for example as a pharmaceutically acceptable carrier. The invention also relates to pharmaceutical compositions containing said products and to the use thereof for the preparation of a medicament.
    Type: Application
    Filed: September 29, 2009
    Publication date: July 21, 2011
    Applicants: Ipsen Pharma S.A.S., Commissariat a L'Energie Atomique Aux Energies Alternatives (C.E.A.), Le Centre National De Recherche Scientifique (CNRS)
    Inventors: Marie-Thérèse Paternostre, Jean-Christophe Cintrat, Céline Valery, Stéphane Roux, Bernard Rousseau, Maarten Ijsselstijn, Roland Cherif-Cheikh, Frank Artzner
  • Publication number: 20110129876
    Abstract: Described herein are molecules, constructs and methods for the production and secretion of polypeptides of interest by host cells, preferably bacterial host cells, and more particularly gram positive bacteria. In particular, the present invention is related to a polynucleic acid encoding a fusion protein and to uses thereof for the secretion of heterologous or homologous polypeptides of interest by a bacterial host cell, preferably Clostridium bacteria. The present invention further relates to methods and constructs for the production and secretion of heterologous or homologous polypeptides of interest proteins by host cells using such polynucleic acids and fusion proteins.
    Type: Application
    Filed: July 30, 2009
    Publication date: June 2, 2011
    Applicants: Total S.A., Le Centre National De Recherche Scientifique (CNRS), L'Universite de la Mediterranee, L'Universite de Provence, L'Instutut National des Sciences Appliquees (INSA)
    Inventors: Henri-Pierre Fierobe, Florence Mingardon, Angélique Chanal-Vial
  • Publication number: 20100190894
    Abstract: The disclosure relates to a bitumen/polymer composition comprising at least one bitumen and at least one graft polymer, the grafts enabling the bitumen/polymer compositions to be thermoreversibly cross-linked. The disclosure also relates to the use of said bitumen/polymer compositions in fields of application relating to roads, especially in the production of asphalt binders, and in industrial fields of application. The disclosure further relates to the method for producing said thermoreversibly cross-linked bitumen/polymer compositions.
    Type: Application
    Filed: July 18, 2008
    Publication date: July 29, 2010
    Applicants: TOTAL RAFFINAGE MARKETING, CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Pierre Chaverot, Charlotte Godivier, Ludwik Leibler, Ilias Iliopoulos, Amanda Kathryn Leach
  • Publication number: 20100008894
    Abstract: The invention relates to a complex formed between the 3?-phosphoadenosine 5?-phosphate and polypeptide in human cells, to the use of pAp or of a molecule which mimics pAp for modulating the activity of poly(ADP-ribose)polymerase and small fragment nuclease in human cells, and to process of screening a molecule as a candidate drug for the treatment of diseases where modulation of at least one of the metabolic activities modulated by pAp is needed such as bipolar disorder or related diseases.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 14, 2010
    Applicants: Institute pasteur, Centre National De Recherche Scientifique (CNRS)
    Inventors: Undine Mechold, Vasily Ogryzko, Antoine Danchin